Atomo Diagnostics secures AUD4.5 mn in funding
11-Aug-16, Business Wire
Medical device innovator Atomo Diagnostics today announced it had raised A$4.5 million in new equity funding from a number of professional investors including the New York-based Global Health Investment Fund (GHIF), as well as a company associated with former Managing Director and CEO of Macquarie Group, Allan Moss AO.
%20Atomo%20Diagnostics.jpg "Atomo Diagnostics secures AUD4 5 mn in funding (c) Atomo Diagnostics")
Image: Atomo Diagnostics
The new investment follows receipt of a US$6 million (A$7.8 million) loan to Atomo by GHIF in Jan-16. Former Macquarie Group Limited Managing Director and CEO Allan Moss is an active investor in the medical device sector and emerging disruptive global technologies.
Mr. Moss said, "Atomo has developed a remarkably user-friendly and accurate testing device which has the potential to assist greatly in detecting HIV and other diseases in Africa and globally."